250 related articles for article (PubMed ID: 19442659)
1. Identification of LOXL1 protein and Apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry.
Sharma S; Chataway T; Burdon KP; Jonavicius L; Klebe S; Hewitt AW; Mills RA; Craig JE
Exp Eye Res; 2009 Oct; 89(4):479-85. PubMed ID: 19442659
[TBL] [Abstract][Full Text] [Related]
2. MALDI MS imaging analysis of apolipoprotein E and lysyl oxidase-like 1 in human lens capsules affected by pseudoexfoliation syndrome.
Ronci M; Sharma S; Martin S; Craig JE; Voelcker NH
J Proteomics; 2013 Apr; 82():27-34. PubMed ID: 23411028
[TBL] [Abstract][Full Text] [Related]
3. Novel protein constituents of pathological ocular pseudoexfoliation syndrome deposits identified with mass spectrometry.
Sharma S; Chataway T; Klebe S; Griggs K; Martin S; Chegeni N; Dave A; Zhou T; Ronci M; Voelcker NH; Mills RA; Craig JE
Mol Vis; 2018; 24():801-817. PubMed ID: 30713420
[TBL] [Abstract][Full Text] [Related]
4. Differential gene expression in pseudoexfoliation syndrome.
Zenkel M; Pöschl E; von der Mark K; Hofmann-Rummelt C; Naumann GO; Kruse FE; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3742-52. PubMed ID: 16186358
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations.
Schlötzer-Schrehardt U
Exp Eye Res; 2009 Apr; 88(4):776-85. PubMed ID: 18809397
[TBL] [Abstract][Full Text] [Related]
6. Atomic force microscopy-based antibody recognition imaging of proteins in the pathological deposits in pseudoexfoliation syndrome.
Creasey R; Sharma S; Gibson CT; Craig JE; Ebner A; Becker T; Hinterdorfer P; Voelcker NH
Ultramicroscopy; 2011 Jul; 111(8):1055-61. PubMed ID: 21740868
[TBL] [Abstract][Full Text] [Related]
7. Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material.
Zenkel M; Kruse FE; Jünemann AG; Naumann GO; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2006 May; 47(5):1982-90. PubMed ID: 16639006
[TBL] [Abstract][Full Text] [Related]
8. Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome.
Zenkel M; Krysta A; Pasutto F; Juenemann A; Kruse FE; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8488-95. PubMed ID: 21948647
[TBL] [Abstract][Full Text] [Related]
9. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients.
Schlötzer-Schrehardt U; Pasutto F; Sommer P; Hornstra I; Kruse FE; Naumann GO; Reis A; Zenkel M
Am J Pathol; 2008 Dec; 173(6):1724-35. PubMed ID: 18974306
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Profiles of LOXL-1, FBN1, TGF-β1, and COX-2 in Pseudoexfoliation Syndrome.
Papadopoulou M; Papadaki H; Zolota V; Gartaganis SP
Curr Eye Res; 2017 Jun; 42(6):880-889. PubMed ID: 28085506
[TBL] [Abstract][Full Text] [Related]
11. Transgenic lysyl oxidase homolog 1 overexpression in the mouse eye results in the formation and release of protein aggregates.
Zadravec P; Braunger BM; Melzer B; Kroeber M; Bösl MR; Jägle H; Schlötzer-Schrehardt U; Tamm ER
Exp Eye Res; 2019 Feb; 179():115-124. PubMed ID: 30399364
[TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of the clusterin gene in pseudoexfoliation syndrome.
Burdon KP; Sharma S; Hewitt AW; McMellon AE; Wang JJ; Mackey DA; Mitchell P; Craig JE
Mol Vis; 2008 Sep; 14():1727-36. PubMed ID: 18806885
[TBL] [Abstract][Full Text] [Related]
13. Proteomics of pseudoexfoliation materials in the anterior eye segment.
Morris J; Myer C; Cornet T; Junk AK; Lee RK; Bhattacharya SK
Adv Protein Chem Struct Biol; 2021; 127():271-290. PubMed ID: 34340770
[TBL] [Abstract][Full Text] [Related]
14. [Latent TGF-beta 1 binding protein (LTBP-1); a new marker for intra-and extraocular PEX deposits].
Schlötzer-Schrehardt U; Küchle M; Hofmann-Rummelt C; Kaiser A; Kirchner T
Klin Monbl Augenheilkd; 2000 Jun; 216(6):412-9. PubMed ID: 10919121
[TBL] [Abstract][Full Text] [Related]
15. Lysyl oxidase-like 1 gene in the reversal of promoter risk allele in pseudoexfoliation syndrome.
Dubey SK; Hejtmancik JF; Krishnadas SR; Sharmila R; Haripriya A; Sundaresan P
JAMA Ophthalmol; 2014 Aug; 132(8):949-55. PubMed ID: 24809751
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E genotypes in pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
Krumbiegel M; Pasutto F; Mardin CY; Weisschuh N; Paoli D; Gramer E; Weber BH; Kruse FE; Schlötzer-Schrehardt U; Reis A
J Glaucoma; 2010; 19(8):561-5. PubMed ID: 20543710
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of exfoliation deposits.
Ovodenko B; Rostagno A; Neubert TA; Shetty V; Thomas S; Yang A; Liebmann J; Ghiso J; Ritch R
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1447-57. PubMed ID: 17389470
[TBL] [Abstract][Full Text] [Related]
18. Impaired cytoprotective mechanisms in eyes with pseudoexfoliation syndrome/glaucoma.
Zenkel M; Kruse FE; Naumann GO; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5558-66. PubMed ID: 18055805
[TBL] [Abstract][Full Text] [Related]
19. The management of exfoliative glaucoma.
Ritch R
Prog Brain Res; 2008; 173():211-24. PubMed ID: 18929111
[TBL] [Abstract][Full Text] [Related]
20. LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma.
Schlötzer-Schrehardt U; Hammer CM; Krysta AW; Hofmann-Rummelt C; Pasutto F; Sasaki T; Kruse FE; Zenkel M
Ophthalmology; 2012 Sep; 119(9):1832-43. PubMed ID: 22633114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
